June 19, 2018 3:52 AM ET


Company Overview of Rapid Pharmaceuticals AG

Company Overview

Rapid Pharmaceuticals AG is a biopharmaceutical company that discovers, develops, and manufactures stable peptide-based medicines for infectious, neurodegenerative, and inflammatory diseases. Its peptide therapeutics platform targets the modulation of cell surface receptors of the innate immune system. The company develops RAP101, a solution for progressive multifocal leukoencephalopathy; RAP112, a solution for immune reconstitution inflammatory syndrome; RAP 102, a solution for multiple sclerosis; and RAP701, a solution for mild traumatic brain injury. It also engages in the research of RAP200 for autism spectrum disorders; RAP103 for neuropathic pain; RAP104 for diabetic neuropathy; and RA...

Neuhofstrasse 5A

Baar,  6340


Founded in 2007


41 44 585 37 27

Key Executives for Rapid Pharmaceuticals AG

Chairman of Executive Board and Chief Executive Officer
Chief Financial Officer
Age: 58
Chief Medical Advisor - Neuropathic Pain and mTBI
Chief Medical Advisor - PML and Member of Advisory Board
Laboratory Director
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
4bases S.A. Europe
AB2 Bio Ltd. Europe
ADC Products Switzerland SARL Europe
ADC Therapeutics SA Europe
AgroSustain Sàrl Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rapid Pharmaceuticals AG, please visit www.rapidpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.